arrow close cutting-edge facebookfeatured global-network globe insights linkedin news-events play search spotlights twitter wireless-expertise youtube

Edico Genome has developed the DRAGEN™ Bio-IT Processor, the world’s first next-generation sequencing reconfigurable bioinformatics processor. This processor is able to analyze the large amounts of data generated by next-generation sequencing rapidly and cost effectively, without compromising accuracy.

Stay Connected

Nothing in these materials is an offer to sell any of the components or devices referenced herein. References to "Qualcomm" may mean Qualcomm Incorporated, or subsidiaries or business units within the Qualcomm corporate structure, as applicable. Materials that are as of a specific date, including but not limited to press releases, presentations, blog posts and webcasts, may have been superseded by subsequent events or disclosures. Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses. Qualcomm products referenced on this page are products of Qualcomm Technologies, Inc. and/or its subsidiaries.